authors
- Ansell, JE
- Laulicht, B
- Bakhru, S
- Steiner, S
- Noveck, R
- Brown, K
- Grosso, M
- Morishima, Y
- Dishy, V
- Mercuri, Mat
Aripazine reverses unfractionated and low molecular weight heparins, fondaparinux and new Xa and IIa oral anticoagulants: report of Phase I/II clinical trial with edoxaban
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- September 1, 2014
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- Cardiovascular System & Hematology (Science Metrix)
published in
- European Heart Journal Journal